tiprankstipranks
GoodRx reports Q3 adjusted EPS 7c, consensus 4c
The Fly

GoodRx reports Q3 adjusted EPS 7c, consensus 4c

Reports Q3 revenue $187.3M, consensus $185.33M. "We are pleased with the progress made in the third quarter despite near-term challenges," said Doug Hirsch, co-CEO and co-founder of GoodRx. "We achieved better-than-expected results and addressed the grocer issue in August. While we continued to see some impact from the grocer issue as we expected, the third quarter was highlighted by double-digit growth in our subscription and pharma manufacturer solutions platforms. Our retail and PBM partnerships remain resilient, and we expanded and enhanced our overall ecosystem this quarter while engaging more deeply with providers and consumers as we work to improve access to affordable healthcare."

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on GDRX:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles